# Arcus Biosciences, Inc.: insider transactions

RCUS · NYSE · CIK 1724521 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rcus.md) · [Financials](/companies/rcus/financials.md) · [Filings](/companies/rcus/filings.md) · [Insiders](/companies/rcus/insiders.md)

## All transactions: 4

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2025-02-18 | [Gilead Sciences, Inc.](/insiders/882095.md) | 10% owner | Purchase (P) | 1,363,636 | $11.00 | $15.0m | [Form 4](/filings/0001062993-25-003084.md) |
| 2024-01-29 | [Gilead Sciences, Inc.](/insiders/882095.md) | 10% owner | Purchase (P) | 15,238,095 | $21.00 | $320.0m | [Form 4](/filings/0001104659-24-008868.md) |
| 2023-06-28 | [Gilead Sciences, Inc.](/insiders/882095.md) | 10% owner | Purchase (P) | 1,010,000 | $19.26 | $19.5m | [Form 4](/filings/0001104659-23-077015.md) |
| 2021-01-31 | [Gilead Sciences Inc](/insiders/882095.md) | 10% owner | Purchase (P) | 5,650,000 | $39.00 | $220.3m | [Form 4](/filings/0001104659-21-010972.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.